Radiation zaps heart arrhythmia: 4-Year study launches
NCT ID NCT06744530
First seen Apr 30, 2026 · Last updated Jun 23, 2026 · Updated 6 times
Summary
This study tracks 50 people with a severe, hard-to-treat heart rhythm problem called ventricular tachycardia. They receive a single, high-dose radiation treatment (STAR) aimed at the heart tissue causing the trouble. Researchers will monitor how well the treatment controls the abnormal rhythm and affects quality of life over 48 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENTRICULAR TACHYCARDIA (VT) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
UZ Leuven
RECRUITINGLeuven, 3000, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
stereotactic radiotherapy ablation (STAR)
What this could lead to
If successful, this could confirm STAR as a safe and effective long-term option for controlling ventricular tachycardia when other treatments fail.
What could go wrong
This is an observational study with no control group, so results may not prove cause and effect. Long-term safety and effectiveness are still being evaluated.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.